National Cancer Registration and Analysis Service, Public Health England, London, and Cancer Research UK, London.
National Disease Registration, National Cancer Registration and Analysis Service, Public Health England, London.
Br J Gen Pract. 2018 Jan;68(666):e63-e72. doi: 10.3399/bjgp17X694169. Epub 2017 Dec 18.
Continual improvements in diagnostic processes are needed to minimise the proportion of patients with cancer who experience diagnostic delays. Clinical audit is a means of achieving this.
To characterise key aspects of the diagnostic process for cancer and to generate baseline measures for future re-audit.
Clinical audit of cancer diagnosis in general practices in England.
Information on patient and tumour characteristics held in the English National Cancer Registry was supplemented by information from GPs in participating practices. Data items included diagnostic timepoints, patient characteristics, and clinical management.
Data were collected on 17 042 patients with a new diagnosis of cancer during 2014 from 439 practices. Participating practices were similar to non-participating ones, particularly regarding population age, urban/rural location, and practice-based patient experience measures. The median diagnostic interval for all patients was 40 days (interquartile range [IQR] 15-86 days). Most patients were referred promptly (median primary care interval 5 days [IQR 0-27 days]). Where GPs deemed diagnostic delays to have occurred (22% of cases), patient, clinician, or system factors were responsible in 26%, 28%, and 34% of instances, respectively. Safety netting was recorded for 44% of patients. At least one primary care-led investigation was carried out for 45% of patients. Most patients (76%) had at least one existing comorbid condition; 21% had three or more.
The findings identify avenues for quality improvement activity and provide a baseline for future audit of the impact of 2015 National Institute for Health and Care Excellence guidance on management and referral of suspected cancer.
需要不断改进诊断流程,以尽量减少经历诊断延误的癌症患者比例。临床审核是实现这一目标的一种手段。
描述癌症诊断过程中的关键方面,并为未来的再审核生成基线措施。
在英格兰的普通诊所进行癌症诊断的临床审核。
英格兰国家癌症登记处保存的患者和肿瘤特征信息,辅以参与实践的全科医生的信息。数据项包括诊断时间点、患者特征和临床管理。
从 2014 年的 439 家诊所收集了 17042 名新诊断癌症患者的数据。参与实践与非参与实践相似,特别是在人口年龄、城乡位置和基于实践的患者体验措施方面。所有患者的中位诊断间隔为 40 天(四分位距[IQR] 15-86 天)。大多数患者都能迅速得到转介(中位初级保健间隔 5 天[IQR 0-27 天])。在全科医生认为存在诊断延误的情况下(22%的病例),分别有 26%、28%和 34%的病例归因于患者、临床医生或系统因素。为 44%的患者记录了安全网措施。至少进行了一次初级保健主导的调查,占 45%的患者。大多数患者(76%)至少有一种现有合并症;21%的患者有三种或更多。
这些发现确定了质量改进活动的途径,并为未来审核 2015 年国家卫生与保健卓越研究所关于疑似癌症的管理和转诊指南的影响提供了基线。